About Us

What is Femara?

Femara is a third-generation non-steroidal selective aromatase inhibitor marketed under the name Femara by the pharma giant Novartis. Its main use is to fight breast cancer in post-menopausal women.

It is very similar in structure and action to Arimidex, which is used in the U.S. for the same purpose. Femara is usually used as a second-line treatment when estrogen receptor antagonists like tamoxifen have not had the desired effect. Femara and arimidex are the newest drugs in a long line of aromatase inhibitor drugs. They work more effectively, more selectively than the first generation drugs, teslac and cytadren. The dosage of one pill of 2.5 mg which is enough for reduction by 78 % of maintenance of an estrogen in a body, at clinical application. At the same time, the drug is already effective in much lower doses.

According to clinical studies, doses of 0.1-0.5mg already reduced estrogen in the blood by 75-78%. As with other medications, the typical recommended dose is just enough to work for anyone. Most people are sensitive to low doses, but to be sure of the effect, the dose is increased. It is important to note that compared to receptor antagonists like clomid\nolvadex, femara has a negative effect on the metabolism of “good” cholesterol.
If you just want to prevent gynecomastia, water retention – it is better to use nolvadex/clomid. But if you want a more powerful effect, take femara.